Drug intelligence / Profile preview

YST plant jam

Development stage: Unknown
Lead developer: Shanghai General Hospital
Modality: Small Molecules
Administration: Oral

Overview

YST plant jam is a natural product currently undergoing investigation for its efficacy and safety in patients diagnosed with carotid atherosclerosis. This product is developed by the Natural Medicine Institute of Zhejiang YangShengTang Co., Ltd. and Shanghai General Hospital. It is administered orally as a jam.

Other names: YST植物果酱

Beyond the preview

Go deeper on YST plant jam.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on YST plant jam.

Explore the full profile